Efficacy and safety of pemafibrate (K-877), a selective peroxisome proliferator-activated receptor α modulator, in patients with dyslipidemia: Results from a 24-week, randomized, double blind, active-controlled, phase 3 trial
| Autor: | Ishibashi, Shun, Arai, Hidenori, Yokote, Koutaro, Araki, Eiichi, Suganami, Hideki, Yamashita, Shizuya |
|---|---|
| Zdroj: | In Journal of Clinical Lipidology January-February 2018 12(1):173-184 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect